Induction of DT-diaphorase in cancer chemoprevention and chemotherapy

Oncology Research

Volumn 9, Issue 6-7, 1997, Pages 371-382

  Begleiter, Asher ^a   Leith, Marsha K ^a   Curphey, Thomas J ^a   Doherty, Geoffrey P ^a  

^a Manitoba Cancer Treatment and Research Foundation   (Canada)

Author keywords

Bioreductive antitumor agents; Chemoprevention; Chemotherapy; Dithiolethiones; Dt diaphorase; Mitomycin c

Indexed keywords

ANTINEOPLASTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL; BIOSYNTHESIS; BIOTRANSFORMATION; DRUG DETOXIFICATION; ENZYME INDUCTION; ENZYMOLOGY; HUMAN; METABOLISM; MOUSE; NEOPLASM; RAT; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; ENZYME INDUCTION; HUMANS; METABOLIC DETOXICATION, DRUG; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASMS; RATS;

EID: 0031308138     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Riley, R. J.; Workman, P. DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol. 43:1657-1669; 1992.
2. Ernster, L. DT-diaphorase: A historical review. Chem. Scripta27A:1-13; 1987.
3. Jaiswal, A. K. Human NAD(P)H:quinone oxidoreductase (NQO-1) gene structure and induction by dioxin. Biochemistry 30:10647-10653; 1991.
4. Jaiswal, A K.; Burnett, P.; Adesnik, M.; McBride, O. W. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 29:1899-1906; 1990.
5. Belinsky, M.; Jaiswal, A. K. NAD(P)H:quinone oxidoreductasel (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev. 12:103-117; 1993.
6. Bayney, R. M.; Rodkey, J. A.; Bennett, C. D.; Lu, A. Y.; Picketi, C. B. Rat liver NAD(P)H:quinone reductase nucleotide sequence analysis of a quinone reductase cDNA clone and prediction of the amino acid sequence of the corresponding protein. J. Biol. Chem. 262:572-575; 1987.
7. Benson, A. M.; Hunkeler, M. J.; Talalay, P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77:5216-5220; 1980.
8. Schlager, J. J.; Powis, G. Cytosolic NAD(P)H:(quinoneacceptor)oxidoreductase in human normal and tumor tissue: Effects of cigarette smoking and alcohol. Int. J. Cancer 45: 403-409; 1990.
9. Fitzsimmons, S. A.; Workman, P.; Grever, M.; Paull, K.; Camalier, R.; Lewis, A. D. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9. J. Natl. Cancer Inst. 88:259-269; 19%.
10. Beyer, R. E.; Segura Aguilar, J. E.; Ernster, L. The anticancer enzyme DT diaphorase is induced selectively in liver during ascites hepatoma growth. Anticancer Res. 8:233-238; 1988.
11. Prestera, T.; Zhang, Y.; Spencer, S. R.; Wilczak, C. A.; Talalay, P. The electrophile counterattack response: Protection against neoplasia and toxicity. Adv. Enzyme Regul. 33:281-296; 1993.
12. Ross, D.; Siegel, D.; Beall, H.; Prakash, A. S.; Mulcahy, R. T.; Gibson, N. W. DT-diaphorase in activation and detoxification of quinones. Cancer Metastasis Rev. 12:83-101; 1993.
13. Prochaska, H. J.; Talalay, P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:4776-4782; 1988.
14. Favreau, L. V.; Picket!, C. B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266:4556-4561 ; 1991.
15. Favreau, L. V.; Picket!, C. B. Transcriptional regulalion of the ral NAD(P)H:quinone reduciase gene, characterization of a DNA-protein interaction at the antioxidant responsive element and induction by 12-o-tetradecanoylphorbol 13-acetate. J. Biol. Chem. 268:19875-19881; 1993.
16. Yao, K. S.; Xanthoudakis, S.; Curran, T.; O'Dwyer, P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14:5997-6003; 1994.
17. Wang, B.; Williamson, G. Transcriptional regulation of the human NAD(P)H:quinone oxidoreductase (NQO1) gene by monofunctional inducers. Biochim. Biophys. Acta 1307:104-110; 1996.
18. Yao, K.; O'Dwyer, P. J. Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DTdiaphorase) by hypoxia, oltipraz and mitomycin. Biochem. Pharmacol. 49:275-282; 1995.
19. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res. 45:1-8; 1985.
20. Prestera, T.; Holtzclaw, W. D.; Zhang, Y.; Talalay, P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA 90:2965-2969; 1993.
21. Egner, P. A.; Kensler, T. W.; Prestera, T.; Talalay, P.; Libby, A. H.; Joyner, H. H.; Curphey, T. J. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15:177-181; 1994.
22. Kensler, T. W.; Egner, P. A.; Dolan, P. M.; Groopman, J. D.; Roebuck, B. D. Mechanism of protection against afia- toxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-l,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones nd 1,2-dithioI-3-ones. Cancer Res. 47:4271-4277; 1987.
23. Ansher, S. S.; Dolan, P.; Bueding, E. Biochemical effects of dithiothiones. Food Chem. Toxicol. 24:405-415; 1986.
24. Kensler, T. W.; Groopman, J. D.; Roebuck, B. D; Curphey, T. J. Chemoprotection by 1,2-dithiole-3-thiones. In: Ho, CT.; Huang, M-T.; Osawa, T.; Rosen, R. T., eds. Food phytochemicals for cancer Chemoprevention. Washington, DC: American Chemical Society; 1994:154-163.
25. Kensler, T. W.; Groopman, J. D.; Eaton, D. L.; Curphey, T. J.; Roebuck, B. D. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13:95-100; 1992.
26. Archer, S. The chemotherapy of schistosomiasis. Annu. Rev. Pharmacol. Toxicol. 25:485-508; 1985.
27. Kelloff, G. J.; Boone, C. W.; Malone, W. F.; Steele, V. E. Chemoprotection clinical trials. Mutât. Res. 267:291-295; 1992.
28. O'Dwyer, P. J.; Szarka, C. E.; Yao, K. S.; Halbherr, T. C.; Pfeiffer, G. R.; Green, F.; Gallo, J. M.; Brennan, J.; Frucht, H.; Goosenberg, E. B.; Hamilton, T. C.; Litwin, S.; Balshem, A. M.; Engstrom, P. F.; Clapper, M. L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest. 98: 1210-1217; 1996.
29. Maxuitenko, Y. Y.; Curphey, T. J.; Kensler, T. W.; Roebuck, B. D. Protection against aflatoxin B,-induced hepatic toxicity
30. as a short-term screen of cancer chemopreventive dithiolethiones. Fundam. Appl. Toxicol. 32:250-259; 1996.
31. Wattenberg, L. \V.; Bueding, E. Inhibitory effects of 5-(2pyrazinyl)-4-methyl-l,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis 7:1379-1381; 1986.
32. Roebuck, B. D.; Liu, Y.; Rogers, A. E.; Groopman, J. D.; Kensler, T. W. Protection against aflatoxin B,-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-l,2dithiole-3-thione (oltipraz): Predictive role for short-term molecular dosimetry. Cancer Res. 51:5501-5506; 1991.
33. Kensler, T. W.; Groopman, J. D.; Roebuck, B. D. Chemoprotection by oltipraz and other dithiolethiones. In: Wattenberg. L.; Lipkin, M.; Boone, C.; Kelloff, G., eds. Cancer chemoprevention. Boca Raton, FL: CRC Press; 1992: 205-225.
34. Zhang, Y.; Talalay, P.; Cho, C. G.; Posner, G. H. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 89:2399-2403; 1992.
35. Zhang, Y.; Kensler, T. W.; Cho, C. G.; Posner, G. H.; Talalay, P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA 91:3147-3150; 1994.
36. Clapper, M. L.; Szarka, C. E.; Pfeiffer, G. R.; Graham, T. A.; Balshem, A. M.; Litwin, S.; Goosenberg, E. B.; Frucht, H.; Engstrom, P. F. Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity. Clin. Cancer Res. 3:25-30; 1997.
37. Workman, P.; Stratford, I. J. The experimental development of bioreductive drugs and their role in cancer therapy. Cancer Metastasis Rev. 12:73-82; 1993.
38. Rockwell, S.; Sartorelli, A. C.; Tomasz, M.; Kennedy, K. A. Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev. 12:165-176; 1993.
39. Hortobagyi, G. N. Mitomycin: Its evolving role in the treatment of breast cancer. Oncology 50(Suppl. l):l-8; 1993.
40. Folman, R. S. Experience with mitomycin in the treatment of non-small cell lung cancer. Oncology 50(Suppl. 1):24-30; 1993.
41. Spain, R. C. The case for mitomycin in non-small cell lung cancer. Oncology 50(SuppI. l):35-52; 1993.
42. Cummings, B. J.; Keane, T. J.; O'Sullivan, B.; Wong, C. S.; Cation, C. N. Mitomycin in anal canal carcinoma. Oncology 50(Suppl. I):63-69; 1993.
43. Coia, L. R. The use of mitomycin in esophageal cancer. Oncology 50(SuppI. l):53-62; 1993.
44. Schnall, S.; Macdonald, J. S. Mitomycin therapy in gastric cancer. Oncology 50(Suppl. l):70-77; 1993.
45. Sekine, H.; Fukui, I.; Yamada, T.; Ohwada, F.; Yokokawa, M.; Ohshima, H. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: A longer followup result. J. Urol. 151:27-30; 1994.
46. Rockwell, S.; Keyes, S. R.; Sartorelli, A. C. Preclinical studies of porfiromycin as an adjunct to radiotherapy. Radial. Res. 116:100-113:1988.
47. Chamberlain, M. C.; Prados, M. D.; Silver, P.; Levin, V. A. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors. J. Neurooncol. 6:319-323; 1988.
48. Schellens, J. H. M.; Planting, A. S. T.; Van Acker, B. A. C.; Loos, W. J.; De Boer-Dennert, M.; Van der Burg, M. E. L.; Koier, I.; Krediet, R. T.; Stoter, G.; Verweij, J. Phase I and pharmacologie study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J. Natl. Cancer Inst. 86:906-912; 1994.
49. Doherty, N.; Hancock, S. L.; Kaye, S.; Coleman, C. N.; Shulman, L.; Marquez, C.; Mariscal, C.; Rampling, R.; Senan, S.; Roemeling, R. V. Muscle cramping in phase I clinical trials of tirapazamine (SR4233) with and without radiation. Int. J. Radiât. Oncol. Biol. Phys. 29:379-382; 1994.
50. Smid, L.; Lesnicar, H.; Zakotnik, B.; Soba, E.; Budihna, M.; Furlan, L.; Zargi, M.; Rudolf, Z. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin in inoperable head and neck cancer-preliminary report. Int. J. Radial. Oncol. Biol. Phys. 32:769-775; 1995.
51. Adams, G. E.; Stratford, I. J. Bioreductive drugs for cancer therapy: The search for tumor specificity. Int. J. Radial. Oncol. Biol. Phys. 29:231-238; 1994.
52. Crooke, S. T.; Bradner, W. T. Mitomycin C: A review. Cancer Treat. Rev. 3:121-139; 1976.
53. Pan, S. S.; Andrews, P. A.; Glover, C. J.; Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem. 259:959-966; 1984.
54. Keyes, S. R.; Fracasso, P. M.; Heimbrook, D. C.; Rockwell, S.; Sugar, S. G.; Sartorelli, A. C. Role of NADPHxytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin Cl. Cancer Res. 44:5638-5643; 1984.
55. Siegel, D.; Gibson, N. W.; Preusch, P. C.; Ross, D. Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 50:7483-7489; 1990.
56. Pan, S. S.; Iracki, T.; Bachur, N. R. DNA alkylation by enzymeactivated mitomycin C. Mol. Pharmacol. 29:622-628; 1986.
57. Tomasz, M.; Lipman, R.; Chowdary, D.; Pawlak, L.; Verdine, G. L.; Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235:1204-1208; 1987.
58. Pritsos, C. A.; Sartorelli, A. C. Generation of reactive oxygen radicals through bioactivation of mitomycin C antibiotics. Cancer Res. 46:3528-3532; 1986.
59. Tomasz, M. Hydroxyl radical production by free and DNAbound aminoquinone antibiotics and its role in DNA degradation. Electron spin resonance detection of hydroxyl radicals by spin trapping. Chem. Biol. Interact. 13:89-97; 1976.
60. town, J. W.; Begleiter, A.; Johnson, D.; Morgan, A. R. Studies related to antitumor antibiotics. Part V. Reaction of mitomycin C with DNA examined by ethidium fluorescence assay. Can. J. Biochem. 54:110-119; 1976.
61. Doroshow, J. H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl. Acad. Sci. USA 83:4514-4518; 1986.
62. Dusre, L.; Covey, J. M.; Collins, C.; Sinha, B. K. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells. Chem. Biol. Interact. 71:63-78; 1989.
63. Hodnick, W. F.; Sartorelli, A. C. Reductive activation of mitomycin C by NADHxytochrome b5 reductase. Cancer Res. 53:4907-4912; 1993.
64. Plumb, J. A.; Gerritsen, M.; Milroy, R.; Thomson, P.; Workman, P. Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines. Int. J. Radiât. Oncol. Biol. Phys. 29:295-299; 1994.
65. Begleiter, A.; Robotham, E.; Lacey, G.; Leith, M. K. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett. 45:173-176; 1989.
66. Gustafson, D. L.; Pritsos, C. A. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst. 84:1180-1185; 1992.
67. Begleiter, A.; Robotham, E.; Leith, M. K. The role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol. Pharmacol. 41:677-682; 1992.
68. Dulhanty, A. M.; Whitmore, G. F. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. Cancer Res. 51: 1860-1865; 1991.
69. Marshall, R. S.; Paterson, M. C.; Rauth, A. M. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer 59: 341-346; 1989.
70. Keyes, S. R.; Rockwell, S.; Sartorelli, A. C. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res. 49:3310-3313; 1989.
71. Siegel, D.; Gibson, N. W.; Preusch, P. C.; Ross, D. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): Role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 50:7293-7300; 1990.
72. Patterson, A. V.; Robertson, N.; Houlbrook, S.; Stephens, M. A.; Adams, G. E.; Harris, A. L.; Stratford, I. J.; Carmichael, J. The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233). Int. J. Radiât. Oncol. Biol. Phys. 29:369-372; 1994.
73. Atallah, A. S.; Landolph, J. R.; Ernster, L.; Hochstein, P. DT-diaphorase activity and the cytotoxicity of quinones in C3H/10T1/2 mouse embryo cells. Biochem. Pharmacol. 37: 2451-2459; 1988.
74. Begleiter, A.; Leith, M. K. Activity of quinone alkylating agents in quinone-resistant cells. Cancer Res. 50:2872-2876; 1990.
75. Kennedy, K. A.; McGurl, J. D.; Leondaridis, L.; Alabaster, O. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Res. 45:3541-3547; 1985.
76. Begleiter, A.; Leith, M. K. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Mol. Pharmacol. 44:210-215; 1993.
77. Begleiter, A.; Leith, M. K. Selective induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro. Biochem. Pharmacol. 50:1281-1286; 1995.
78. Begleiter, A.; Leith, M. K.; Curphey, T. J. Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents. Br. J. Cancer 74(Suppl. 27):S9-S14; 1996.
79. Shao, Y.; Pardini, L.; Pardini, R. S. Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30:1035-1045; 1995.
80. Prochaska, H. J.; Santamaria, A. B. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. 169:328-336; 1988.
81. Coulombel, L.; Eaves, A. C.; Eaves, C. J. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood 62:291-297; 1983.
82. Johnston, J. B.; Verbürg, L.; Shore, T.; Williams, M.; Israels, L. G.; Begleiter, A. Combination therapy with nucleoside analogs and alkylating agents. Leukemia 8(Suppl.):S140S143; 1994.